Movicol Pediátrico Sabor Chocolate

Macrogol 3350, the active ingredient in Movicol Pediátrico Sabor Chocolate, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and related bowel conditions in children. GNH USA supplies Movicol Pediátrico Sabor Chocolate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Pediátrico, an osmotic laxative, is used to manage conditions affecting bowel function.

- Constipation: softens stool and promotes regular bowel movements in pediatric patients. - Fecal impaction: helps relieve impacted stool by increasing water content in the colon. - Bowel preparation: used to cleanse the bowel before diagnostic procedures such as colonoscopy.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of unease or urge to vomit. - Mild abdominal pain: discomfort in the stomach area. - Diarrhoea: loose, watery stools. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium or potassium. - Severe dehydration: significant loss of body fluids. - Allergic reaction: rash, itching, swelling, or angioedema. - Severe abdominal pain: intense, persistent pain. - Rectal bleeding: presence of blood in stool. - Colonic perforation: rare tearing of the colon wall.

Before prescribing Movicol Pediátrico, consider the following precautions.

- Assess renal function: adjust use in patients with renal impairment. - Monitor electrolytes: watch for hyponatremia or hyperkalemia. - Use with caution in dehydration: ensure adequate fluid intake. - Avoid in intestinal obstruction: contraindicated in mechanical blockage. - Pediatric dosing: follow prescriber instructions carefully. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Movicol Pediátrico may interact with other medicines; review the following.

Major Interactions (Avoid): - Other osmotic laxatives: risk of severe electrolyte disturbances. - Loop diuretics: may exacerbate dehydration and electrolyte loss. - Anticholinergic agents: may reduce efficacy of bowel movement.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment when combined with dehydration. - Antacids containing magnesium: may enhance laxative effect. - Oral rehydration solutions: monitor electrolyte balance when used together.